morgan stanley glp 1 Here's Why Analysts Downgraded Novo Nordisk's Stock The Real Drivers of GLP-1
Description
Blood Sugar Improvements: For clients using Semaglutide to manage type 2 diabetes, improvements in blood sugar levels may be noticeable within the first few weeks of treatment

The mean eGFR at baseline was 87 mL/min/1.73 m2 and 7% of the patients had an eGFR less than 60 mL/min/1.73 m2

And none have been shown to produce meaningful weight loss when delivered through a patch

A GLP-1 agonist is a type of medication that mimics a hormone our bodies naturally produce: GLP-1 (glucagon-like peptide-1)

40 , e65e77 (2020)

A good metric to consider is this: If an obese patient (BMI 30 to 34.9) is on a GLP-1 for six months and has not reached 10% TBWL, they should be referred back to their primary care provider to reassess their weight-loss plan
